Latest Insider Transactions at Edesa Biotech, Inc. (EDSA)
This section provides a real-time view of insider transactions for Edesa Biotech, Inc. (EDSA). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of Edesa Biotech, Inc. to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of Edesa Biotech, Inc.'s insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Nov 12
2024
|
Pardeep Nijhawan Chief Executive Officer |
BUY
Grant, award, or other acquisition
|
Direct |
4,630
+3.26%
|
-
|
|
Oct 02
2024
|
Pardeep Nijhawan Chief Executive Officer |
BUY
Grant, award, or other acquisition
|
Direct |
3,300
+2.43%
|
-
|
|
Sep 03
2024
|
Pardeep Nijhawan Chief Executive Officer |
BUY
Grant, award, or other acquisition
|
Direct |
3,055
+2.31%
|
-
|
|
Aug 01
2024
|
Pardeep Nijhawan Chief Executive Officer |
BUY
Grant, award, or other acquisition
|
Direct |
3,317
+2.56%
|
-
|
|
Jul 02
2024
|
Pardeep Nijhawan Chief Executive Officer |
BUY
Grant, award, or other acquisition
|
Direct |
4,015
+3.16%
|
-
|
|
Jun 03
2024
|
Pardeep Nijhawan Chief Executive Officer |
BUY
Grant, award, or other acquisition
|
Direct |
4,785
+3.87%
|
-
|
|
May 01
2024
|
Pardeep Nijhawan Chief Executive Officer |
BUY
Grant, award, or other acquisition
|
Direct |
3,083
+2.63%
|
-
|
|
Apr 01
2024
|
Pardeep Nijhawan Chief Executive Officer |
BUY
Grant, award, or other acquisition
|
Direct |
3,253
+2.85%
|
-
|
|
Mar 25
2024
|
Pardeep Nijhawan Chief Executive Officer |
BUY
Open market or private purchase
|
Indirect |
5,000
+1.44%
|
$20,000
$4.0 P/Share
|
|
Mar 01
2024
|
Pardeep Nijhawan Chief Executive Officer |
BUY
Grant, award, or other acquisition
|
Direct |
2,765
+2.5%
|
-
|
|
Feb 01
2024
|
Pardeep Nijhawan Chief Executive Officer |
BUY
Grant, award, or other acquisition
|
Direct |
2,978
+2.76%
|
-
|
|
Jan 08
2024
|
Pardeep Nijhawan Chief Executive Officer |
BUY
Grant, award, or other acquisition
|
Direct |
2,908
+2.77%
|
-
|
|
Aug 04
2023
|
Pardeep Nijhawan Chief Executive Officer |
BUY
Grant, award, or other acquisition
|
Direct |
99,300
+12.52%
|
-
|
|
Aug 04
2023
|
Michael J Brooks President |
BUY
Grant, award, or other acquisition
|
Direct |
93,200
+42.97%
|
-
|
|
Aug 04
2023
|
Stephen Lemieux Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
17,400
+50.0%
|
-
|
|
Jan 10
2023
|
Velden Peter Van Der > 10% Shareholder |
SELL
Open market or private sale
|
Indirect |
152,345
-7.9%
|
$304,690
$2.63 P/Share
|
|
Jan 09
2023
|
Velden Peter Van Der > 10% Shareholder |
SELL
Open market or private sale
|
Indirect |
145,129
-7.0%
|
$290,258
$2.66 P/Share
|
|
Nov 02
2022
|
Pardeep Nijhawan Chief Executive Officer |
BUY
Grant, award, or other acquisition
|
Indirect |
456,524
+29.41%
|
$456,524
$1.12 P/Share
|
|
Nov 02
2022
|
Kathi Niffenegger Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Indirect |
8,888
+45.34%
|
$8,888
$1.12 P/Share
|
|
Nov 02
2022
|
Michael J Brooks President |
BUY
Grant, award, or other acquisition
|
Direct |
4,239
+12.21%
|
$4,239
$1.12 P/Share
|
|
Jun 30
2022
|
Pardeep Nijhawan Chief Executive Officer |
BUY
Open market or private purchase
|
Direct |
20,000
+3.25%
|
$20,000
$1.6 P/Share
|
|
Jun 29
2022
|
Michael J Brooks President |
BUY
Open market or private purchase
|
Direct |
3,000
+10.26%
|
$3,000
$1.49 P/Share
|
|
Jun 16
2022
|
Michael J Brooks President |
BUY
Open market or private purchase
|
Direct |
3,000
+11.43%
|
$3,000
$1.61 P/Share
|
|
May 27
2022
|
Pardeep Nijhawan Chief Executive Officer |
BUY
Open market or private purchase
|
Direct |
5,000
+0.86%
|
$5,000
$1.92 P/Share
|
|
May 25
2022
|
Michael J Brooks President |
BUY
Open market or private purchase
|
Direct |
3,500
+14.74%
|
$3,500
$1.74 P/Share
|
|
May 24
2022
|
Pardeep Nijhawan Chief Executive Officer |
BUY
Open market or private purchase
|
Direct |
2,000
+0.35%
|
$2,000
$1.8 P/Share
|
|
Mar 31
2022
|
Pardeep Nijhawan Chief Executive Officer |
BUY
Open market or private purchase
|
Direct |
2,000
+0.35%
|
$4,000
$2.99 P/Share
|
|
Mar 30
2022
|
Pardeep Nijhawan Chief Executive Officer |
BUY
Open market or private purchase
|
Direct |
2,000
+0.35%
|
$6,000
$3.05 P/Share
|
|
Mar 29
2022
|
Pardeep Nijhawan Chief Executive Officer |
BUY
Open market or private purchase
|
Direct |
2,000
+0.35%
|
$6,000
$3.02 P/Share
|
|
Mar 18
2022
|
Pardeep Nijhawan Chief Executive Officer |
BUY
Open market or private purchase
|
Direct |
2,000
+0.35%
|
$6,000
$3.85 P/Share
|
|
Mar 17
2022
|
Pardeep Nijhawan Chief Executive Officer |
BUY
Open market or private purchase
|
Direct |
2,000
+0.18%
|
$6,000
$3.26 P/Share
|
|
Mar 15
2022
|
Pardeep Nijhawan Chief Executive Officer |
BUY
Open market or private purchase
|
Direct |
2,000
+0.36%
|
$4,000
$2.8 P/Share
|
|
Mar 14
2022
|
Michael J Brooks President |
BUY
Open market or private purchase
|
Direct |
1,250
+6.95%
|
$2,500
$2.79 P/Share
|
|
Mar 11
2022
|
Pardeep Nijhawan Chief Executive Officer |
BUY
Open market or private purchase
|
Direct |
7,000
+0.63%
|
$21,000
$3.12 P/Share
|
|
Mar 10
2022
|
Michael J Brooks President |
BUY
Open market or private purchase
|
Direct |
1,000
+6.06%
|
$3,000
$3.22 P/Share
|
|
Mar 09
2022
|
Pardeep Nijhawan Chief Executive Officer |
BUY
Open market or private purchase
|
Direct |
1,500
+0.27%
|
$4,500
$3.05 P/Share
|
|
Mar 08
2022
|
Michael J Brooks President |
BUY
Open market or private purchase
|
Direct |
1,250
+7.94%
|
$2,500
$2.9 P/Share
|
|
Mar 25
2021
|
Michael J Brooks President |
BUY
Open market or private purchase
|
Direct |
3,500
+20.91%
|
$17,500
$5.19 P/Share
|
|
Mar 25
2021
|
Pardeep Nijhawan Chief Executive Officer |
BUY
Open market or private purchase
|
Direct |
3,000
+0.55%
|
$15,000
$5.25 P/Share
|
|
Mar 24
2021
|
Pardeep Nijhawan Chief Executive Officer |
BUY
Open market or private purchase
|
Direct |
5,000
+0.91%
|
$25,000
$5.16 P/Share
|
|
Mar 24
2021
|
Michael J Brooks President |
BUY
Open market or private purchase
|
Direct |
4,500
+31.6%
|
$22,500
$5.08 P/Share
|
|
Feb 18
2021
|
Frank R. Oakes |
SELL
Open market or private sale
|
Direct |
6,165
-100.0%
|
$43,155
$7.25 P/Share
|
|
Feb 18
2021
|
Frank R. Oakes |
SELL
Open market or private sale
|
Indirect |
1,827
-100.0%
|
$12,789
$7.25 P/Share
|
|
Nov 09
2020
|
Lorin K Johnson |
BUY
Exercise of in-the-money or at-the-money derivatives securities
|
Direct |
4,262
+25.0%
|
$17,048
$4.0 P/Share
|
|
Nov 06
2020
|
Paul William Pay |
BUY
Exercise of in-the-money or at-the-money derivatives securities
|
Direct |
1,218
+25.0%
|
$4,872
$4.0 P/Share
|
|
Nov 06
2020
|
Kathi Niffenegger Chief Financial Officer |
BUY
Exercise of in-the-money or at-the-money derivatives securities
|
Indirect |
609
+25.0%
|
$2,436
$4.0 P/Share
|
|
Nov 06
2020
|
Michael J Brooks President |
BUY
Exercise of in-the-money or at-the-money derivatives securities
|
Direct |
914
+14.85%
|
$3,656
$4.0 P/Share
|
|
Nov 05
2020
|
Pardeep Nijhawan Chief Executive Officer |
BUY
Exercise of in-the-money or at-the-money derivatives securities
|
Indirect |
4,628
+0.22%
|
$18,512
$4.0 P/Share
|
|
Nov 05
2020
|
Carlo Sistilli |
BUY
Exercise of in-the-money or at-the-money derivatives securities
|
Indirect |
1,218
+25.0%
|
$4,872
$4.0 P/Share
|
|
Nov 02
2020
|
Velden Peter Van Der > 10% Shareholder |
BUY
Exercise of in-the-money or at-the-money derivatives securities
|
Indirect |
70,314
+3.28%
|
$281,256
$4.0 P/Share
|